Rule register

Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications

At a glance

Citation
21 CFR 1307.41; 42 CFR 12.1 (Fourth Temporary Extension, 90 FR 61301; Docket No. DEA-407)
Type
Final rule
Status
Effective (as of November 14, 2026)2 This is a temporary rule. The current text of 21 CFR 1307.41 states that the section is in effect until the end of the day December 31, 2026.2
Applies to
DEA-registered practitioners, and practitioners exempt from registration under 21 U.S.C. 822(d), who prescribe schedule II-V controlled substances via telemedicine to patients they have not evaluated in person.
Sectors
Healthcare
Jurisdiction
United States (federal)

Key dates

Key dates Each date is copied from the source its number links to, checked unless the row shows another date. Upcoming or passed as of .
DateKindWhatWhenSource
KindPublishedWhatFourth temporary rule published in the Federal Register (90 FR 61301)WhenPassedSource1
KindEffectiveWhatFourth temporary extension takes effectWhenPassedSource1
KindDeadlineWhatTelemedicine prescribing flexibilities expire at the end of this dayWhenUpcomingSource2

What it changed

The fourth temporary rule amends 21 CFR 1307.41 and 42 CFR 12.1 so that the authorization expires at the end of December 31, 2026 instead of December 31, 2025. It sits alongside two final rules published on January 17, 2025, for buprenorphine treatment and for Veterans Affairs patients, which the rule says go into effect on December 31, 2025.

Not listed

  • The temporary rule describes DEA's separate proposal for a Special Registration for Telemedicine (90 FR 6541, January 17, 2025). That is a different rulemaking, so its dates are not listed here.3

Sources

  1. Office of the Federal Register (Federal Register API). Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, FR Doc. 2025-24123 (90 FR 61301, December 31, 2025), Federal Register API record. Checked .
  2. Electronic Code of Federal Regulations (Office of the Federal Register). 21 CFR 1307.41, Temporary extension of certain COVID-19 telemedicine flexibilities for prescription of controlled medications (eCFR current to November 12, 2026). Checked .
  3. Drug Enforcement Administration. Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications, public inspection copy of FR Doc. 2025-24123. Checked .

How we source and check every fact: Editorial standards · Corrections

Last reviewed . Statuses and dates change: check the source before you rely on one.

Spotted an error? Tell us and we will check it and correct the entry where needed.